Benzidine
|
CAS
92-87-5
|
NH2C6H4C6H4NH2
|
RTECS
DC9625000
|
Synonyms & Trade Names
Benzidine-based dyes; 4,4'-Bianiline; 4,4'-Biphenyldiamine; 1,1'-Biphenyl-4,4'-diamine; 4,4'-Diaminobiphenyl; p-Diaminodiphenyl [Note: Benzidine has been used as a basis for many dyes.]
|
DOT ID & Guide
1885 / 153
|
Exposure Limits
|
NIOSH REL: Ca See Appendix A See Appendix C
|
OSHA PEL: [1910.1010] See Appendix B See Appendix C
|
IDLH
Ca [N.D.]
See: IDLH INDEX
|
Conversion
|
Physical Description
Grayish-yellow, reddish-gray, or white crystalline powder. [Note: Darkens on exposure to air and light.]
|
MW: 184.3
|
BP: 752°F
|
MLT: 239°F
|
Sol(54°F): 0.04%
|
VP: Low
|
IP: ?
|
|
Sp.Gr: 1.25
|
Fl.P: ?
|
UEL: ?
|
LEL: ?
|
|
Combustible Solid, but difficult to burn.
|
Incompatibilities & Reactivities
Red fuming nitric acid
|
Measurement Methods
NIOSH 5509; OSHA 65
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated/Daily
Remove: When wet or contaminated
Change: Daily
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations (See Appendix E)
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape: (APF = 50) Any air-purifying, full-facepiece respirator with an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Hematuria (blood in the urine); secondary anemia from hemolysis; acute cystitis; acute liver disorders; dermatitis; painful, irregular urination; [potential occupational carcinogen]
|
Target Organs
Bladder, skin, kidneys, liver, blood
Cancer Site
[liver, kidney & bladder cancer]
|
See also: INTRODUCTION
See ICSC CARD: 0224 See MEDICAL TESTS: 0023
|